Prognostic significance of the SIRI in gastrointestinal malignancy patients: a pooled analysis of 10091 participants - supplementary material

PRISMA 2020 ChecklistTable S1. Quality assessment of included studies.Table S2. Meta-regression analyses for the association of confounding factors and the hazard ratio for OS and DFS.Figure S1. The flowchart of study selection.Figure S2. Sensitivity analyses for OS (A) and DFS (B) between the high SIRI and low SIRI groups in GI malignanciesFigure S3. Begg’s funnel plots for OS (A) and DFS (B) between the high SIRI and low SIRI groups in GI malignancies.

PRISMA 2020检查表（PRISMA 2020 Checklist）。补充表S1：纳入研究的质量评估。补充表S2：针对混杂因素与总生存期（overall survival, OS）和无病生存期（disease-free survival, DFS）风险比的关联开展的Meta回归分析。补充图S1：研究筛选流程图。补充图S2：胃肠恶性肿瘤（gastrointestinal malignancies, GI malignancies）中高SIRI组与低SIRI组的总生存期（OS）与无病生存期（DFS）敏感性分析（A、B分别对应OS、DFS）。补充图S3：胃肠恶性肿瘤中高SIRI组与低SIRI组的总生存期（OS）与无病生存期（DFS）的Begg漏斗图（A、B分别对应OS、DFS）。